Global Infertility Diagnosis and Treatment Market 2022-2028: Surging Consumption of Tobacco Products Drives Growth - ResearchAndMarkets.com

The global infertility diagnosis and treatment market is anticipated to grow at a substantial CAGR of 7.0% during the forecast period.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Friday, November 18, 2022
Information
Tags: 
Health, Other Health, Diagnosis, Semen analysis, Infertility, Artificial insemination, ART, IUI, Hysteroscopy, Female, Hysterosalpingography, Medicine, ICSI, Tobacco, Woman, Reproductive technology, Medical tourism, Growth, Fertilisation, Fertility, Male, Smoking, Genetic testing, Medical device, Birth control
Geotags: 
ASIA, EUROPE, INDIA, CHINA, NORTH AMERICA
Organisation: 
RESEARCH AND MARKETS
Summary
Key Points: 
  • The global infertility diagnosis and treatment market is anticipated to grow at a substantial CAGR of 7.0% during the forecast period.
  • The growth of the global infertility diagnosis and treatment market during the forecast period can be attributed to the increase in the level of smoking.
  • The global infertility diagnosis and treatment market is segmented based on diagnosis and treatment.
  • Global Infertility Diagnosis and Treatment Market Research and Analysis by Infertility Treatment.


The "Global Infertility Diagnosis and Treatment Market 2022-2028" report has been added to ResearchAndMarkets.com's offering.

The global infertility diagnosis and treatment market is anticipated to grow at a substantial CAGR of 7.0% during the forecast period. The growth of the global infertility diagnosis and treatment market during the forecast period can be attributed to the increase in the level of smoking.

Additionally, the surging consumption of smoking products directly influences demand and supply for the market. Furthermore, the consumption of tobacco and tobacco-related products affects the fertility level in both men and women. Hence, the rising level of smoking is driving the growth of the market.

The global infertility diagnosis and treatment market is segmented based on diagnosis and treatment. Based on the diagnosis, the market is segmented into male infertility diagnosis (semen analysis, genetic testing, testicular biopsy, hormone testing, and others) and female infertility diagnosis (ovulation testing, hysterosalpingography, hysteroscopy, imaging testing, ovarian reserve testing, hormonal level testing, genetic testing, others testing).

Based on the treatment, the market is segmented into male infertility treatment (drugs and medicine, surgical, assisted reproductive technology (ART), Others) and female infertility treatment (drugs and medicine, surgical, intrauterine insemination (IUI), assisted reproductive technology (ART), in vitro fertilization, intracytoplasmic sperm injection (ICSI), assisted hatching, others). Among these, the female infertility treatment segment is anticipated to grow during the forecast period due to decreasing rates of fertility among females, the growing availability of various fertility treatment options, and the increasing number of fertility centers across the globe.

Geographically, the global infertility diagnosis and treatment market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America holds a prominent share in the market due to the changing lifestyle and increasing geriatric population. Furthermore, Asia-Pacific is anticipated to hold the market share following North America due to the increasing healthcare expenditure and increasing medical tourism in major countries such as China and India in the region in the region.

Market Segmentation

  1. Global Infertility Diagnosis and Treatment Market Research and Analysis by Diagnosis.
  2. Global Infertility Diagnosis and Treatment Market Research and Analysis by Infertility Treatment.

Key Topics Covered:

1. Report Summary

2. Market Overview and Insights

3. Competitive Landscape

4. Market Segmentation

5. Regional Analysis

6. Company Profiles

Companies Mentioned

  • Bayer AG
  • Bristol-Myers Squibb Co.
  • Church & Dwight Co.Inc.
  • Cook Medical, Inc.
  • Coopersurgical Inc.
  • Eli Lilly & Co.
  • EMD Serono, Inc
  • Endo Pharmaceuticals Inc.
  • Ferring Pharmaceuticals
  • Genea
  • Glaxosmithkline Plc
  • HalotechDna
  • Irvine Scientific
  • Janssen Pharmaceutical
  • Novartis International Ag
  • Origio
  • Ovascience
  • Pfizer Inc.
  • Princeton Biomeditech Corp.
  • Progyny
  • Quidel Corp
  • Vitrolife Ab
  • Vivus Inc.

For more information about this report visit https://www.researchandmarkets.com/r/v4g1es

Copyright: 
Copyright Business Wire 2022